Nomogram for predicting the overall survival and disease-specific survival of adult patients with primary diffuse large B-cell lymphoma, leg type based on the SEER database

基于SEER数据库的成人原发性弥漫性大B细胞淋巴瘤(腿型)患者总生存期和疾病特异性生存期预测列线图

阅读:1

Abstract

Primary diffuse large B-cell lymphoma, leg type (PCDLBCL, LT) is a rare lymphoma with a poor prognosis. An accurate predictive model for the prognosis of these patients is lacking. Here, we retrospectively analyzed the clinical data of 968 adult patients who were diagnosed with PCDLBCL, LT between 2000 and 2020 obtained from the Surveillance, Epidemiology and End Results (SEER) database. Multivariate Cox regression analysis revealed that age, marital status and radiation were independent prognostic factors for overall survival (OS), while age, Ann Arbor stage and radiation were independent prognostic factors for disease-specific survival (DSS). Nomograms were constructed to predict 1-, 3- and 5-year OS and DSS. The concordance indices, receiver operating characteristic curves and calibration curves revealed that the established nomograms had good accuracy in predicting the outcomes of patients with PCDLBCL, LT. The web-based calculators were subsequently developed to provide individualized predictions for OS and DSS in patients with PCDLBCL, LT. Moreover, according to the risk scores of the nomograms, patients were divided into low-, median-, and high-risk groups. In conclusion, the nomograms and accompanying web-based survival calculators offer practical tools for individualized prediction of OS and DSS in patients with PCDLBCL, LT. Risk stratification based on these tools may assist clinicians in identifying high-risk patients and guiding optimal treatment decisions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00277-025-06692-5.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。